FOXM1 and breast cancer: FoxM1 mRNA high expression was correlated to shorter RFS in BC patients with ER positive tumors (HR = 1.9, p = 3.1e-13) (Figure 5B), and PR positive tumors (HR = 2.66, p = 1.3e-07) (Figure 5C).